Discover Tenders by Non Decaffeinated Coffee Sector

Find the most relevant tenders for Non Decaffeinated Coffee. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Decaffeinated Coffee tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Decaffeinated Coffee tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Interferon Beta 1A Exclusively For Subcutaneous Use Atc L03Ab07 For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8798282

EMD:Ref Document

Bid Value: Ref Document

365 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgotinib L04Af04 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8796348

EMD:Ref Document

Bid Value: Ref Document

360 Days Left

Open House Drug Rebate Agreements Sorafenib Atc L01Ex02

Deadline: 05 Sep 2026

Germany

Ref. No.: 8793928

EMD:Ref Document

Bid Value: Ref Document

365 Days Left

Open House Drug Discount Agreements Naproxen Atc M01Ae02

Deadline: 05 Sep 2026

Germany

Ref. No.: 8793766

EMD:Ref Document

Bid Value: Ref Document

365 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgrastim L03Aa02 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8791885

EMD:Ref Document

Bid Value: Ref Document

360 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Golimumab L04Ab06 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8791055

EMD:Ref Document

Bid Value: Ref Document

360 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ciclosporin S01Xa18

Deadline: 10 Aug 2026

Germany

Ref. No.: 8790550

EMD:Ref Document

Bid Value: Ref Document

339 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoietin B03Xa01 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8789001

EMD:Ref Document

Bid Value: Ref Document

360 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Olanzapine N05Ah03 Without Solid Oral Dosage Forms As Part Of A So Called Open Hou

Deadline: 31 Aug 2026

Germany

Ref. No.: 8788988

EMD:Ref Document

Bid Value: Ref Document

360 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Sultiam N03Ax03 Only Film Coated Tablets Within The Framework Of A So Called Open

Deadline: 31 Aug 2026

Germany

Ref. No.: 8788968

EMD:Ref Document

Bid Value: Ref Document

360 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lanreotide Atc H01Cb03 Obo For The Period 01 11 2024 31 10 2025 Plus Extension Option 1X12 Months

Deadline: 05 Sep 2026

Germany

Ref. No.: 8788391

EMD:Ref Document

Bid Value: Ref Document

365 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Clobetasol D07Ad01 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8785935

EMD:Ref Document

Bid Value: Ref Document

360 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ebastine R06Ax22 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8785335

EMD:Ref Document

Bid Value: Ref Document

360 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Cinacalcet Excl Strength 30Mg 60Mg 90Mg In Standard Size N3 Atc H05Bx01 For The Period 01 11 24 31 10 26

Deadline: 05 Sep 2026

Germany

Ref. No.: 8784387

EMD:Ref Document

Bid Value: Ref Document

365 Days Left

Open House Drug Discount Agreements Etanercept Atc L04Ab01

Deadline: 05 Sep 2026

Germany

Ref. No.: 8783296

EMD:Ref Document

Bid Value: Ref Document

365 Days Left

Showing 24256 to 24270 of 24943 results

‹
1
2
...
1615
1616
1617
1618
1619
1620
1621
...
1662
1663
›

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

FREE Trial plan for all new users!